Optical Genome Mapping Market Research Report Information by Product (Instruments, Consumables and Reagents, Software, and Services), by Application (Structural Variant Detection, Genome Assembly, Microbial Strain Typing, and Others), by End-User (Biotechnology and Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2032

Global Optical Genome Mapping Market Overview

Optical Genome Mapping Market Size was valued at USD 0.12 Billion in 2022. The Optical Genome Mapping Market industry is projected to grow from USD 0.15 Billion in 2023 to USD 1.15 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 28.60% during the forecast period (2024 - 2032). The increasing demand for personalized medicine, driven by a growing knowledge of the importance of tailored treatments and advancements in imaging technologies and bioinformatics, is expected to be a significant market driver for the Optical Genome Mapping Market.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Optical Genome Mapping Market Trends

Growing investment in R&D by major market participants, as well as increased partnerships among academic institutions and industrial partners, are driving the market growth

Market CAGR for Optical Genome Mapping is driven by the growing investment in R&D by major market participants, as well as increased partnerships among academic institutions and industrial partners. The surge in government initiatives to delve deeper into genome mapping is propelling market growth. For instance, the Government of India, Ministry of Science & Technology sanctioned a project named 'Genome India: Cataloguing the Genetic Variation in Indians' in March 2020, as reported by the Press Information Bureau. This project, centered on Whole Genome Sequencing (WGS), aims to complete sequencing for 10,000 individuals within three years, representing the diverse population of the country. Optical genome mapping laid the groundwork for whole-genome sequencing, facilitating genome assembly by aligning sequenced DNA fragments to the genome map. The insights derived from whole-genome sequencing are expected to enhance the precision of future human genetics research in the country. Additionally, it will enable the development of a genome-wide association array tailored to the Indian population, leading to the creation of cost-effective precision healthcare and diagnostics for prevalent diseases.

Industry players are employing various marketing strategies such as mergers, acquisitions, and product launches. For example, in June 2022, Hamilton and Bionano Genomics, Inc. announced a collaboration to develop the Long String VANTAGE, designed for the isolation of Ultra High Molecular Weight (UHMW) DNA for optical genome mapping (OGM). A crucial step in Bionano's sample preparation workflow is the extraction of high-quality and quantity UHMW DNA. Traditionally, this process is manually performed by highly skilled laboratory personnel, limiting the amount of DNA extracted and its usability in regular sample preparation. As a result, it is anticipated that throughout the projection period, demand for the Optical Genome Mapping Market will increase due to the Growing investment in R&D by major market participants, as well as increased partnerships among academic institutions and industrial partners. Thus, driving the Optical Genome Mapping Market revenue.

Optical Genome Mapping Market Segment Insights

Optical Genome Mapping Market Product Insights

The   Optical Genome Mapping Market segmentation, based on Product, includes Instruments, Consumables and Reagents, Software, and Services. The services segment dominated the market, accounting for 58% of market revenue. These services include sample preparation, data analysis, and interpretation, all of which are conducted by proficient professionals utilizing state-of-the-art technologies to ensure precise mapping and analysis of genomic structures. Researchers find value in outsourcing the intricate task of optical genome mapping, allowing them to concentrate on their scientific inquiries without being encumbered by complex technical procedures.

Figure 1:   Optical Genome Mapping Market, by Product, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Optical Genome Mapping Market Application Insights

The   Optical Genome Mapping Market segmentation, based on Application, includes Structural Variant Detection, Genome Assembly, Microbial Strain Typing, and Others. The Structural Variant Detection segment dominated the market, accounting for 58% of market revenue. Structural variants, including insertions, deletions, duplications, and translocations, play crucial roles in genetic diversity and can contribute to the onset of various diseases, such as cancer and genetic disorders. The high-resolution imaging techniques of optical genome mapping empower researchers and clinicians to comprehensively detect these variations. By generating detailed genomic maps, this technology facilitates a more profound comprehension of the genetic mechanisms underlying diseases, thus fostering the development of targeted therapies and personalized medicine strategies.

Optical Genome Mapping Market End-User Insights

The   Optical Genome Mapping Market segmentation, based on End-User, includes Biotechnology and Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, and Others. The Academic Research Institutes segment dominated the market, accounting for 60% of market revenue. Academic Research Institutes, serving as pillars of scientific inquiry, are pivotal in advancing genomic understanding. Within these institutions, researchers utilize optical genome mapping to delve deeply into the complexities of the human genome and other organisms. This cutting-edge technology enables academics to perform thorough genetic analyses, investigating structural variations and comprehending disease mechanisms at a profound depth. These insights fuel pioneering discoveries, propelling advancements in fields like cancer research, genetics, and evolutionary biology.

Optical Genome Mapping Market Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Optical Genome Mapping market in North America can be attributed to several key factors. The advancement in genetic research has propelled a particular region to the forefront. In a Tedtalk Podcast episode by the United States Food and Drug Administration aired in 2021, titled "Whole Genome Sequencing in the New Era of Smarter Food Safety," the discussion centered around the increasing utilization of whole-genome sequencing in both public and private sectors for food safety. Whole-genome sequencing (WGS) stands as a pioneering technology adopted by the FDA for innovative and health-centric purposes. By unveiling the complete DNA composition of an organism, WGS allows the FDA to gain deeper insights into genetic variations within and between species. The integration of optical genome mapping has further simplified the process of genome sequencing, facilitating the FDA in distinguishing between species with an unprecedented level of accuracy not achievable with current technologies.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2:   OPTICAL GENOME MAPPING MARKET SHARE BY REGION 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Optical Genome Mapping Market accounts for the second-largest market share as the European optical genome mapping market is propelled by factors such as the expanding elderly population prone to genetic conditions, the expanding utilization of genome analysis in oncology, and the growing investment in genome research endeavors. In June 2023, The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), in collaboration with Exact Sciences, Guardant Health, Illumina, MSD, and Novartis, introduced the European Coalition for Access to Comprehensive Genomic Profiling (ECGP). This coalition aims to enhance cancer care by advocating for increased routine clinical access and reimbursement of Comprehensive Genomic Profiling (CGP) across Europe. Further, the German Optical Genome Mapping Market held the largest market share, and the UK Optical Genome Mapping Market was the fastest-growing market in the European region.

The Asia-Pacific Optical Genome Mapping Market is expected to grow at the fastest CAGR from 2024 to 2032. The rising awareness of genetic disorders and the expanding accessibility of genetic testing have spurred a greater need for advanced genomic technologies to conduct precise and thorough DNA analyses.  ly, close to 8000 rare genetic diseases have been identified, with approximately 450 reported cases in India alone. These disorders predominantly impact children and impose significant socio-economic, emotional, and physical challenges on affected families. Optical genome mapping stands out for its ability to conduct extensive genome analysis and detect structural variations over long ranges, rendering it an invaluable asset for both research and clinical purposes. Moreover, China’s Optical Genome Mapping Market held the largest market share, and the Indian Optical Genome Mapping Market was the fastest-growing market in the Asia-Pacific region.

Optical Genome Mapping Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development to expand their product lines, which will help the Optical Genome Mapping market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their   footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Optical Genome Mapping industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the   Optical Genome Mapping industry to benefit clients and increase the market sector. In recent years, the Optical Genome Mapping industry has offered some of the most significant advantages to the field of genomics and biomedical research. Major players in the Optical Genome Mapping Market, including Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, Cerba are attempting to increase market demand by investing in research and development operations.

BioNano Genomics provides a technology platform for the analysis of genomic DNA segments and structural variations. The company offers optical genome mapping solutions, including the Saphyr system, variant detection tools, sample preparation kits, and computational solutions for experiment management and bioinformatics processing. BioNano's software portfolio includes VIA software, Nexus Copy Number, and Nxclinical, among others. The company's services encompass data services, OGM data services, laboratory services, and certified services. BioNano operates in China, the UK, and the US, with headquarters in San Diego, California. On June 29, 203, Bionano Genomics, Inc. unveiled the Stratys system, designed for high-throughput optical genome mapping (OGM), along with VIA software, which integrates the visualization, interpretation, and reporting of genome analysis data from OGM, microarrays, and next-generation sequencing (NGS) into one unified software platform.

Nucleome Informatics Private Limited, headquartered in India, stands out as a   customer-centric genomics and bioinformatics company. As a provider of next-generation genomics services, it prioritizes environmentally friendly research practices. The mission at Nucleome is continuous learning and scientific innovation to deliver optimal solutions that align with research objectives. Specializing in NGS and bioinformatics, Nucleome serves as a trusted research partner for scientists engaged in agri-genomics and human genomics studies. The proficient project management team ensures successful project execution within predefined scopes. By strategically implementing customized NGS protocols and bioinformatics pipelines tailored to scientific inquiries, Nucleome has earned a reputation as a dependable research collaborator. It offers next-generation sequencing and bioinformatics services worldwide. The latest version of DrSeq has been developed, enabling scientists to analyze exome sequencing and diagnostics data efficiently. Additionally, Nucleome's genotyping solutions support researchers in pharmacogenomics and personalized medicine endeavors. The Agigenotyping solutions assist agriculture scientists in enhancing breeding programs through marker-assisted selection and GWAS.

Key companies in the Optical Genome Mapping Market include

• Bionano Genomics


• Nucleome Informatics Private Limited


• Praxis Genomics, LLC,


• SourceBio International Limited (Source BioScience)


• MedGenome


• INRAE (French Plant Genomic Resources Center (CNRGV))


• PerkinElmer (PerkinElmer Genomics)


• Genohub Inc.


• Hofkens Lab


• Cerba

Optical Genome Mapping Industry Developments

July 2023: Cerba Healthcare introduced a novel test within the optical genome mapping field. This new-generation cytogenetic diagnostic enables high-resolution analysis of chromosome structures, detecting balanced and unbalanced structural variants down to 500 base pairs. This initiative aims to broaden the company's portfolio.

March 2023: Bionano Genomics Inc. expanded its clinical testing options by introducing Laboratory Developed Tests (LDTs) based on optical genome mapping. These tests cater to prenatal and postnatal analysis. This strategic move is poised to enhance the company's range of services.

Optical Genome Mapping Market Segmentation

Optical Genome Mapping Market Product Outlook

• Instruments


• Consumables and Reagents


• Software


• Services

Optical Genome Mapping Market Application Outlook

• Structural Variant Detection


• Genome Assembly


• Microbial Strain Typing


• Others

Optical Genome Mapping Market End-User Outlook

• Biotechnology and Pharmaceutical Companies


• Clinical Laboratories


• Academic Research Institutes


• Others

Optical Genome Mapping Market Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  

• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America